Filgotinib or lanraplenib in moderate to severe cutaneous lupus erythematosus: a phase 2, randomized, double-blind, placebo-controlled study
菲戈替尼或拉拉普利尼治疗中重度皮肤红斑狼疮：一项 2 期随机、双盲、安慰剂对照研究
期刊:Rheumatology
影响因子:4.4
doi:10.1093/rheumatology/keab685
Werth, Victoria P; Fleischmann, Roy; Robern, Michael; Touma, Zahi; Tiamiyu, Iyabode; Gurtovaya, Oksana; Pechonkina, Alena; Mozaffarian, Afsaneh; Downie, Bryan; Matzkies, Franziska; Wallace, Daniel
